Role of Lung Clearance Index in the Early Detection of Pulmonary Changes in Children with Sickle Cell Disease
| dc.contributor.author | Chaung, Monica | |
| dc.date.accessioned | 2018-03-30T18:12:15Z | |
| dc.date.available | 2018-03-30T18:12:15Z | |
| dc.date.issued | 2018-03-30 | |
| dc.identifier.uri | http://hdl.handle.net/10150/627163 | |
| dc.description | A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine. | en |
| dc.description.abstract | Pulmonary complications including acute chest syndrome are leading causes of sickle cell disease related morbidity and mortality. Studies have shown that pulmonary changes can be detected during childhood. Spirometry is the current standard for measuring lung function. Growing evidence suggests that lung clearance index (LCI) is as sensitive as spirometry in identifying pulmonary changes in pediatric patients. Our cross-sectional study compared the sensitivity of LCI to spirometry in the detection of early pulmonary changes in children with sickle cell disease. Our results show that LCI significantly correlates to FEV1% predicted (Spearman’s coefficient -0.44, p = 0.003), FVC % predicted (Spearman’s coefficient -0.44, p = 0.006) and FEF25-75 (Spearman’s coefficient -0.49, p <0.001). Using receiver operating characteristic (ROC) curves, LCI was found to be more sensitive than spirometry, but less specific. The data support LCI’s use as a test to screen for pulmonary changes in children with sickle cell disease. Earlier monitoring of lung function will allow for preventative therapies and delayed progression of pulmonary dysfunction. | |
| dc.language.iso | en_US | en |
| dc.publisher | The University of Arizona. | en_US |
| dc.rights | Copyright © is held by the author. Digital access to this material is made possible by the College of Medicine - Phoenix, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. | en_US |
| dc.subject | Pulmonary | en |
| dc.subject | Lung Clearance Index | en |
| dc.subject | Children | en |
| dc.subject.mesh | Anemia, Sickle Cell | en |
| dc.subject.mesh | Lung | en |
| dc.subject.mesh | Early Diagnosis | en |
| dc.subject.mesh | Child | en |
| dc.subject.mesh | Adolescent | en |
| dc.subject.mesh | Child, Preschool | en |
| dc.subject.mesh | Infant | en |
| dc.title | Role of Lung Clearance Index in the Early Detection of Pulmonary Changes in Children with Sickle Cell Disease | en_US |
| dc.type | text; Electronic Thesis | en |
| dc.contributor.department | The University of Arizona College of Medicine - Phoenix | en |
| dc.description.collectioninformation | This item is part of the College of Medicine - Phoenix Scholarly Projects 2018 collection. For more information, contact the Phoenix Biomedical Campus Library at pbc-library@email.arizona.edu. | en_US |
| dc.contributor.mentor | Williams, Sophia | en |
| refterms.dateFOA | 2018-08-14T22:50:26Z | |
| html.description.abstract | Pulmonary complications including acute chest syndrome are leading causes of sickle cell disease related morbidity and mortality. Studies have shown that pulmonary changes can be detected during childhood. Spirometry is the current standard for measuring lung function. Growing evidence suggests that lung clearance index (LCI) is as sensitive as spirometry in identifying pulmonary changes in pediatric patients. Our cross-sectional study compared the sensitivity of LCI to spirometry in the detection of early pulmonary changes in children with sickle cell disease. Our results show that LCI significantly correlates to FEV1% predicted (Spearman’s coefficient -0.44, p = 0.003), FVC % predicted (Spearman’s coefficient -0.44, p = 0.006) and FEF25-75 (Spearman’s coefficient -0.49, p <0.001). Using receiver operating characteristic (ROC) curves, LCI was found to be more sensitive than spirometry, but less specific. The data support LCI’s use as a test to screen for pulmonary changes in children with sickle cell disease. Earlier monitoring of lung function will allow for preventative therapies and delayed progression of pulmonary dysfunction. |

